Image - Barts and The London logo and link to home page Image - divider Image - divider
 
  Image - Wolfson Institute of Preventive Medicine title and link to Institute home page
Images - preventive medicine, people
  Image - Centre for Cancer Prevention title and link to CCP homepage
 
Centre for Cancer Prevention publications 2004
Bataille V, Winnett A, Sasieni P, Newton Bishop JA, Cuzick J. Exposure to the sun and sunbeds and the risk of cutaneous melanoma in the UK: a case-control study. Eur J Cancer 2004; 40(3): 429-35. ISSN: 09598049.
Cuzick J. Chemoprevention of breast cancer (letter). Biomed & Pharmacother 2004; 58: 71-73. ISSN: 07533322.
Cuzick J.Screening for cervical cancer. In: Cervical Cancer: From Etiology to Prevention. Rohan TE, Shah KV (Eds). Kluwer Academic Publishers, 2004, 261-99. ISBN: 14020141004.
Cuzick J, Buzdar A, Baum M, Bianco R, Coleman R, Constenla M, Distler W, Dowsett M, Forbes J, Guastalla JP, Houghton J, Williams N, Howell A, Locker G, MacKey J, Sainsbury R, Tobias J. Adjuvant use of anastrozole in breast cancer. J clin Oncol 2004; 22(8): 1524-6. ISSN: 0732183X..
Cuzick J, O’neill C, Hamed H. Genetic and other factors related to tamoxifen-associated venous thromboembolic events. Am J Oncol Rev 2004; 3: 405-406. ISSN: 02773732.
Cuzick J, Warwick J, Pinney E, Warren RML, Duffy SW.Tamoxifen and breast density in women at increased risk of breast cancer. J Natl Cancer Inst 2004; 96: 621-628. ISSN: 00278874.
Duffy SW, Jakes R, Ng FC, Gao F. Interaction of dense breast patterns with other breast cancer risk factors in a case-control study. Br J Cancer 2004; 91: 233-236. ISSN: 00070920.
Duffy SW, Warwick J, Williams ARW, Keshavarz H, Kaffashian F, Rohan TE, Nili F, Sadeghi-Hassanabadi A. A simple model for potential use with misclassified binary outcome in epidemiology. J Epidemiol Comm Hlth 2004; 58: 712-717. ISSN: 0143005X.
Fallowfield L, Cella D, Francis S, Locker G, Howell A. Quality of life of menopausal women in the Arimidex, Tamoxifen, Alone or in Combination (ATAC) adjuvant Breast Cancer Trial. J Clin Oncol 2004; 22(21): 4261-4671. ISSN: 0732183X.
Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, Duffy SW. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 2004 11: 117-125. ISSN: 09691413.
Forrest S , McCaffery K, Waller J, Desai M, Szarewski A, Cadman L, Wardle J. Attitudes to self-sampling for HPV among Indian, Pakistani, African-Caribbean and white British women in Manchester. J Med Screen 2004 11:85–88. ISSN: 09691413.
Harwood CA, Surentheran T, Sasieni P, Proby CM, Bordea C, Leigh IM, Wojnarowska F, Breuer J, McGregor JM. Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 2004;150: 949-57. ISSN: 00070963.
Lipton LR, Johnson V, Cummings C, Fisher S, Risby P, Sadat ATE, Cranston T, Izatt L, Sasieni P, Hodgeson SV, Thomas HJW, Tomlinson IPM. Refining the Amsterdam criteria and Bethesda guidelines: Testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol 2004; 22: 4934-4943. ISSN: 0732183X.
Locker GY, Sainsbury JR, Cuzick J .Breast surgery in the ‘Arimidex, tamoxifen alone or in combination’(ATAC) trial. Cancer 2004; 101: 735-40. ISSN: 0008543X.
McCaffery K, Waller J, Forrest S, Cadman L, Szarewski A, Wardle J. Testing positive for human papillomavirus in routine cervical screening: Examination of psychosocial impact.  BJOG 2004; 111: 1437-43. ISSN: 100935741.
McCann J, Treasure P, Duffy SW. Modelling the impact of detecting and treating carcinoma in situ in a breast screening programme. J Med Screen 2004; 11: 117-125. ISSN: 09691413.
Myles JP, Salminen T, Duffy SW, Prevost TC, Day NE, Hakama M. Prospective estimation of rates of change in mammographic parenchymal patterns: influence of age and of hormone replacement therapy. Breast 2004; 13: 56-60. ISSN: 09609776.
Paci E, Warwick J, Falini P, Duffy SW. Overdiagnosis in service screening: should the increase in breast cancer incidence rates necessarily be a cause for concern? J Med Screen 2004; 11: 23-27. ISSN: 09691413.
Peacock C, Given-Wilson RM, Duffy SW. Mammographic casting type calcification associated with small screen-detected invasive breast cancers: Is this a reliable prognostic indicator? Clin Radiol 2004; 59: 165-170.ISSN: 00099260.
Sasieni P Adams J Cuzick J. Reply: The value of case-control audits of screening. Br J Cancer 2004; 90: 1109-1110. ISSN: 0008543X.
Smith RA, Duffy SW, Gabe R, Tabar L, Yen AMF, Chen HHT. The randomized trials of breast cancer screening: what have we learned? Radiol Clin Nth Amer 2004; 42: 793-806. ISSN: 00338389.
Szarewski A. Injectable progestogens. In: Clinical General Practice, Vol. 2. Selby M (Ed). London, Butterworth Heinemann, 2004, 207- 210. ISBN: 0750687878.
Szarewski A, Cuzick J. Smoking and Cervical Neoplasia. In: Tobacco and Public Health: Science and Policy, Boyle P et al (Eds). Oxford, OUP, 2004, 459-478. ISBN: 0198526873.
Szarewski A, Sasieni P. Cervical screening in adolescents – at least do no harm.  Lancet 2004; 364: 1642-4. ISSN: 01406736.
Tabar L, Yen MF, Vitak B, Chen NN, Smith RA, Duffy SW. Mammography service screening and mortality. Biomed Pharmacother 2004 ;58: 269-270. ISSN: 07533322.
Tabar L, Vitak B, Yen MFA, Chen HHT, Smith RA, Duffy SW. Number needed to screen- lives saved over 20 years of follow-up in mammographic screening. J Med Screen 2004; 11: 126-129. ISSN: 09691413.
Tabar L, Chen HHT, Yen MFA, Tot T, Tung TH, Chen LS, Chu YH, Duffy SW, Smith RA. Mammographic tumor features can reliably predict the long-term outcome of women with 1-14 mm invasive breast cancer: suggestions for revision of current therapeutic practice and the TNM classification system. Cancer 2004; 101: 1745-1759. ISSN: 0008543X.
Terry G, Ho L, Londesborough P, Cross P, Lopes A, Monagham J, Cuzick J. The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions. Brit J Cancer 2004; 91: 2056-2062. ISSN: 00070920.
Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004; 23: 1111-1130. ISSN: 02776715.
Wang J, Shiels C, Sasieni P, Wu PJ, Islam SA, Freemont PS, Sheer D. Promyelocytic leukemia nuclear bodies associate with transcriptionally active genomic regions. J Cell Biol 2004; 164(4): 515-526. ISSN: 00219525
Warren R, Allgood P Hunnan G, Godward S, Duffy SW. An audit of breast assessment procedures in women who later develop cancer after a negative result. J Med Screen 2004; 11: 180-186. ISSN: 09691413.
Warwick J, Tabar L, Vitak B, Duffy SW. Long-term survival with breast cancer: evidence from the Swedish Two-County Study (1977-98). Amer J Oncol Rev 2004; 3: 376-385. ISSN: 02773732.
Warwick J, Tabar L, Vitak B, Duffy SW. Time-dependent effects on survival in breast cancer: results of 20 years follow-up from the Swedish Two County Study. Cancer 100: 1331-1336, 2004. ISSN: 0008543X.
Wong JM, Yen MF, Lai MS, Duffy SW, Smith RA, Chen THH. Progression rates of colorectal cancer by Dukes’ stage in a high-risk group: analysis of selective colorectal cancer screening. Cancer J 2004; 10: 160-169. ISSN: 15289117.
Zappa M, Visioli CB, Ciatto S, Iossa A, Paci E, Sasieni P. Lower protection of cytological screening for adenocarcinomas and shorter protection for younger women: the results of a case-control study in Florence. Br J Cancer 2004; 90: 1784-1786. ISSN: 00070920.
 
Top
 

Useful links:
  WIPM publications hub
    EPM
    CCP
    Psychiatry
    GPRF/EMCU

by CCP Website Manager © Queen Mary, University of London 2011
Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Barts and The London, Charterhouse Square, London EC1M 6BQ Tel: 020 7882 3850  Fax: 020 7882 3890